Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : to Participate in the Virtual Wells Fargo Healthcare Conference

07/27/2021 | 02:50pm EDT

New Brunswick, NJ (July 27th, 2021) -- Johnson & Johnson will participate in the Virtual Wells Fargo Healthcare Conference on Friday, September 10th. Joaquin Duato, Vice Chairman of the Executive Committee will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hours after the live webcast.

###

  • Press Contacts
    Christina Chan
    (732) 524-6297

    Christopher DelOrefice
    (732) 524-2955

    Jen McIntyre
    (732) 524-3922

Disclaimer

Johnson & Johnson published this content on 27 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2021 18:49:06 UTC.


ę Publicnow 2021
All news about JOHNSON & JOHNSON
02:58pCORONAVIRUS : U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mo..
AQ
01:30pJOHNSON & JOHNSON : Pennsylvania Jury Reportedly Finds Johnson & Johnson Baby Power Didn't..
MT
10:20aCDC Recommends Booster Shots of Pfizer-BioNTech COVID-19 Vaccine for Older Adults, High..
MT
09/22JOHNSON & JOHNSON : Unit Signs Deal for HealthVerity Patient Data Platform
MT
09/22PRO BANKRUPTCY BRIEFING : J&J Beats Injury Lawyers on Talc Bankruptcy; Judge Questions Tal..
DJ
09/21JOHNSON & JOHNSON : Unit Collaborates With Persephone Biosciences On Stool Analysis
MT
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
09/21Johnson & Johnson Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to S..
MT
09/21Today on Wall Street: Markets at a pivot point
09/21JOHNSON & JOHNSON : Says New Data Show Booster Shot Increases COVID-19 Protection
MT
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,1x
Yield 2021 2,53%
Capitalization 433 B 433 B -
EV / Sales 2021 4,60x
EV / Sales 2022 4,39x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,86 $
Average target price 185,83 $
Spread / Average Target 12,7%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.75%433 991
ROCHE HOLDING AG10.87%324 441
PFIZER, INC.19.40%247 760
NOVO NORDISK A/S51.58%233 750
ELI LILLY AND COMPANY37.51%210 490
ABBVIE INC.0.20%189 724